PRESS RELEASE published on 07/13/2023 at 13:00, 2 years ago CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights
PRESS RELEASE published on 06/20/2023 at 13:05, 2 years 1 month ago CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma
PRESS RELEASE published on 06/20/2023 at 13:00, 2 years 1 month ago CureVac Appoints International Financial Expert Michael Brosnan to Supervisory Board
PRESS RELEASE published on 06/19/2023 at 17:30, 2 years 1 month ago CureVac Announces Voting Results of General Meeting
PRESS RELEASE published on 05/30/2023 at 13:00, 2 years 1 month ago CureVac Announces Financial Results for the First Quarter of 2023 and Provides Business Update
PRESS RELEASE published on 05/19/2023 at 13:00, 2 years 2 months ago CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech
PRESS RELEASE published on 05/08/2023 at 13:00, 2 years 2 months ago CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK
PRESS RELEASE published on 04/25/2023 at 13:00, 2 years 3 months ago CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update
PRESS RELEASE published on 04/18/2023 at 13:00, 2 years 3 months ago CureVac to Report Fourth Quarter and Full-Year 2022 Financial Results and Business Updates on April 25, 2023
PRESS RELEASE published on 03/28/2023 at 22:05, 2 years 4 months ago CureVac Announces Voting Results of Extraordinary General Meeting
Published on 07/29/2025 at 00:30, 1 hour 50 minutes ago PPX Mining Announces Completion of Debt Settlements
Published on 07/29/2025 at 00:15, 2 hours 5 minutes ago Star Copper Announces Amended and Restated $4 Million LIFE Offering
Published on 07/28/2025 at 22:30, 3 hours 50 minutes ago Eagle Plains Announces Conditional Approval of Warrant Expiry Extension
Published on 07/28/2025 at 22:05, 4 hours 15 minutes ago Organto Foods Announces Appointment of Javier Reyes de la Campa as Co-Chair of the Board
Published on 07/28/2025 at 23:39, 2 hours 41 minutes ago EQS-Adhoc: PALFINGER AG: SUCCESSFUL PLACEMENT OF TREASURY SHARES
Published on 07/28/2025 at 22:21, 3 hours 59 minutes ago EQS-Adhoc: Mynaric expects the capital reduction to zero and subsequent capital increase to take effect shortly, resulting in the current shareholders to leave without compensation and trading to end
Published on 07/28/2025 at 22:15, 4 hours 5 minutes ago Abivax annonce la réalisation de son offre au public de 747,5 millions de dollars
Published on 07/28/2025 at 22:15, 4 hours 5 minutes ago Abivax Announces Closing of $747.5 Million Public Offering
Published on 07/28/2025 at 22:05, 4 hours 15 minutes ago Nyxoah’s DREAM Pivotal Study Data Published in the Journal of Clinical Sleep Medicine
Published on 07/28/2025 at 17:50, 8 hours 30 minutes ago imerys-communiqué-28-juillet-2025-rachat-d-actions-du-21 au 25 juillet 2025
Published on 07/28/2025 at 17:40, 8 hours 39 minutes ago Reporting on share buyback transactions carried out between July 16 and July 22, 2025
Published on 07/28/2025 at 17:40, 8 hours 39 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 22 juillet 2025